Genomic characterization of clinical Enterobacter roggenkampii co-harbouring blaIMP-1- and blaGES-5-encoding IncP6 and mcr-9-encoding IncHI2 plasmids isolated in Japan
Genomic characterization of clinical Enterobacter roggenkampii co-harbouring blaIMP-1- and blaGES-5-encoding IncP6 and mcr-9-encoding IncHI2 plasmids isolated in Japan
复制标题
DOI:
10.1016/j.jgar.2020.11.028
复制
发表时间:
2021-01-28
影响因子:
4.6
通讯作者:
Kawahara, Ryuji
中科院分区:
文献类型:
--
作者:
Umeda, Kaoru;Nakamura, Hiromi;Kawahara, Ryuji
Objectives: The spread of carbapenemase-producing Enterobacterales (CPE) with colistin resistance is a critical public health issue. We genetically characterized the clinical isolate Enterobacter roggenkampii OIPH-N260, which harboured carbapenemase genes bla(IMP-1) and bla(GES-5) with multiple resistance genes, including mcr-9 and bla(CTX-M-9).Methods: This isolate was characterized by whole-genome sequencing, comparative analysis of resistance plasmids, susceptibility tests, bacterial conjugation, S1-nuclease digested pulsed -field-gel electrophoresis, and Southern blot hybridization.Results: The OIPH-N260 isolate exhibited resistance to most beta-lactams and colistin. It co-harboured two resistance plasmids, the blaIMP-1- and blaGES-5-encoding IncP6 plasmid pN260-3 and mcr-9-and bla(CTX-M-9)-encoding IncHI(2) plasmid pN260-1. The comparative analysis of pN260-3 indicated that a unique bla(IMP-1)-surrounding region was inserted into the bla(GES-5)-encoding plasmid with the mobile element IS26, which plays an important role in the spread of resistance genes. pN260-1 did not possess the mcr-9 expression regulative gene qseBC. Both plasmids were transferable into other bacterial species via conjugation.Conclusions: This is the first study to report not only a bla(IMP-1) and bla(GES-5) co-encoding plasmid, but also the co-harbouring of another plasmid carrying mcr-9 and bla(CTX-M-9) in Enterobacter cloacae complex. The development of advanced resistance via IS26-mediated insertion and the co-harbouring of resistance plasmids highlights the need to monitor for resistance genes in CPE. (C) 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.